Filing Flows › CervoMed (CRVO) › Q4 2025
CervoMed (CRVO) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 13, 2026
CervoMed (CRVO) reported revenue of $9K for the fourth quarter 2025 (Q4 2025), -100% from a year earlier and -97% from the quarter before.
CervoMed, Q4 2025: revenue $9K (-100% year over year), net loss $8.1M, operating cash flow −$6.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9K | -97% | -100% |
| Operating profit | −$8.3M | — | — |
| Net earnings | −$8.1M | — | — |
| Operating cash flow | −$6.6M | — | — |
What changed
Revenue was $9K in Q4 2025, down 100% year over year and down 97% from the previous quarter.
Operating costs exceeded revenue by $8.3M, an operating margin of -95479.2%. Total costs fell 11% while revenue fell 100%. The quarter ended with a net loss of $8.1M, wider than the previous quarter's $7.7M loss.
Operating cash flow was −$6.6M. Non-cash charges added back $299K of share-based compensation. Working capital and other items added $1.2M.
Questions
What was CervoMed's revenue in the fourth quarter 2025?
CervoMed (CRVO) reported revenue of $9K for the fourth quarter 2025 (Q4 2025), -100% from a year earlier and -97% from the quarter before.
Source: CervoMed 10-K on SEC EDGAR.